1 Martin, J. A., Hamilton, B. E. & Osterman, M. J. K. Births in the
United States, 2019. NCHS Data Brief , 1-8 (2020).
2 Bell, E. F. et al. Mortality, In-Hospital Morbidity, Care
Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US,
2013-2018. Jama 327 , 248-263,
doi:10.1001/jama.2021.23580 (2022).
3 Yeh, J., McGrath-Morrow, S. A. & Collaco, J. M. Oxygen weaning after
hospital discharge in children with bronchopulmonary dysplasia.Pediatr Pulmonol 51 , 1206-1211, doi:10.1002/ppul.23442
(2016).
4 Hayes, D., Jr. et al. Home Oxygen Therapy for Children. An
Official American Thoracic Society Clinical Practice Guideline.American journal of respiratory and critical care medicine199 , e5-e23, doi:10.1164/rccm.201812-2276ST (2019).
5 Balfour-Lynn, I. M. et al. BTS guidelines for home oxygen in
children. Thorax 64 Suppl 2 , ii1-26,
doi:10.1136/thx.2009.116020 (2009).
6 Lagatta, J., Clark, R. & Spitzer, A. Clinical predictors and
institutional variation in home oxygen use in preterm infants. The
Journal of pediatrics 160 , 232-238,
doi:10.1016/j.jpeds.2011.08.033 (2012).
7 Everitt, L. H. et al. Weaning oxygen in infants with
bronchopulmonary dysplasia. Paediatric respiratory reviews39 , 82-89, doi:10.1016/j.prrv.2020.10.005 (2021).
8 DeMauro, S. B. et al. Home Oxygen and 2-Year Outcomes of
Preterm Infants With Bronchopulmonary Dysplasia. Pediatrics143 , doi:10.1542/peds.2018-2956 (2019).
9 Greenough, A. et al. Preschool healthcare utilisation related
to home oxygen status. Arch. Dis. Child Fetal Neonatal Ed91 , F337-F341 (2006).
10 Lodha, A. et al. Does chronic oxygen dependency in preterm
infants with bronchopulmonary dysplasia at NICU discharge predict
respiratory outcomes at 3 years of age? Journal of perinatology :
official journal of the California Perinatal Association 35 ,
530-536, doi:10.1038/jp.2015.7 (2015).
11 Jobe, A. H. & Bancalari, E. Bronchopulmonary dysplasia. Am J
Respir Crit Care Med 163 , 1723-1729,
doi:10.1164/ajrccm.163.7.2011060 (2001).
12 Gonçalves, J. et al. Cannabis and Its Secondary Metabolites:
Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical
Determination. Medicines (Basel) 6 ,
doi:10.3390/medicines6010031 (2019).
13 Collaco, J. M. & McGrath-Morrow, S. A. Bronchopulmonary dysplasia as
a determinant of respiratory outcomes in adult life. Pediatr
Pulmonol , doi:10.1002/ppul.25301 (2021).
14 Lin, H. et al. Home oxygen use and 1-year outcome among
preterm infants with bronchopulmonary dysplasia discharged from a
Chinese regional NICU. Front Pediatr 10 , 978743,
doi:10.3389/fped.2022.978743 (2022).
15 Aoyama, B. C., McGrath-Morrow, S. A. & Collaco, J. M. Socioeconomic
status and outpatient follow-up in children with bronchopulmonary
dysplasia. Pediatr Pulmonol , doi:10.1002/ppul.26232 (2022).
16 Wong, M. D., Neylan, M., Williams, G., Zahir, S. F. & Chawla, J.
Predictors of home oxygen duration in chronic neonatal lung disease.Pediatr Pulmonol 56 , 992-999, doi:10.1002/ppul.25257
(2021).